The new direction in multiple myeloma blood tests.
EasyM is a liquid biopsy for minimal residual disease (MRD) monitoring in Multiple Myeloma. Earlier relapse detection. Better prognosis.
Sign up to follow our progress with bringing EasyM to the Myeloma community.
How it works.
How it works.
What it is exactly.
What it is exactly.
EasyMTM is a truly personalized, precise monitoring test for patients with Multiple Myeloma (MM) that is non-invasive and highly sensitive. It relies on sequencing the patients’ unique M-protein (a biomarker for MM), and then quantifying the change in M-protein levels over time. It is sensitive enough to detect Multiple Myeloma relapse 10 months earlier than traditional tests. Applied on peripheral blood, the test can be readily performed as frequently as needed, providing each patient with better routine monitoring than available conventional testing.
EasyM is a truly personalized, precise monitoring test for patients with Multiple Myeloma (MM) that is non-invasive and highly sensitive. It relies on sequencing the patients’ unique M-protein (a biomarker for MM), and then quantifying the change in M-protein levels over time. It is sensitive enough to detect Multiple Myeloma relapse 10 months earlier than traditional tests. Applied on peripheral blood, the test can be readily performed as frequently as needed providing each patient with better routine monitoring than available conventional testing.
EasyM versus comparable methods.
Parameter / Method | EasyM | SPEP | IFE | NGS |
---|---|---|---|---|
Sensitivity | ***** | * | ** | **** |
Specificity | ***** | *** | *** | ***** |
Non-invasive | ***** | ***** | ***** | * |
Relapse Detection | ***** | * | * | **** |